glp 1 agonists and sglt2 inhibitors Diabetic Agents, From Metformin to GLP1 Receptor Agonists: JACC Focus Seminar SGLT2 Inhibitors vs. GLP-1 Agonists

Evaluating drug cost per responder and number needed to treat associated with lixisenatide on top of glargine when compared to rapid-acting insulin intensification regimens on top of glargine, in patients with type 2 diabetes in the UK, Italy, and Spain

Physiology & Behavior

The next decade may redefine obesity and metabolic disease management more dramatically than any era since the discovery of insulin.

Surg Obes Relat Dis 15(8):13801387 Altieri MS, Pryor A, Bates A, Docimo S, Talamini M, Spaniolas K (2018) Bariatric procedures in adolescents are safe in accredited centers

Quick Answer: GLP-1 receptor agonists delay gastric emptying as a therapeutic mechanism that contributes to weight loss and glycemic control but can cause gastrointestinal symptoms and perioperative complications

Wang X, Qi M, Yang L, Yang L, Wang X, Zhang F, et al